Company: KCHVR
Filing Date: 2025-08-14
Form Type: 10-Q
Source: 0001213900-25-076631
Chunk: 104

Company: Kochav Defense Acquisition Corp.
Filing Date: 2025-08-14
Form: 10-Q
Item: Part I, Item 2
Chunk 104
---
 be provided the opportunity to have all or a portion of their Public Shares redeemed. Any redemptions will reduce the
amount held in our Trust Account, the effect of which may adversely affect our ability to consummate our initial Business Combination
and may also impair our ability to maintain our Nasdaq listing.

We anticipate that our securities will be
suspended from trading on Nasdaq and delisted if we do not consummate our initial Business Combination by May 27, 2028. Any trading suspension
or delisting could have a material adverse effect on the trading of our securities and may adversely affect our ability to consummate
an initial Business Combination.

Our IPO Registration Statement was declared effective
by the SEC on May 27, 2025 and our securities are currently listed on the Global Market tier of Nasdaq. Pursuant to our Amended and Restated
Articles, we have until May 29, 2027 to consummate our initial Business Combination, if we use the extension of the Combination Period
available to us pursuant to our Amended and Restated Articles.

Under the Nasdaq Rules, a SPAC’s Nasdaq-listed
securities will be immediately suspended from trading if the SPAC does not meet the Nasdaq 36-Month Requirement, and Nasdaq will, at such
point, commence delisting procedures. Although a SPAC can request a hearing before the hearing panel of Nasdaq (the “Hearing Panel”),
the scope of the Hearing Panel’s review is limited. If a SPAC completes a Business Combination after receiving a delisting determination
by the staff of the Listing Qualifications Department of Nasdaq (a “Staff Delisting Determination”) and/or demonstrates compliance
with all applicable initial listing requirements, the combined company can apply to list its securities on Nasdaq pursuant to the normal
application review process. The Nasdaq Rules contain a list of deficiencies that would immediately result in a Staff Delisting Determination,
which includes noncompliance with the Nasdaq 36-Month Requirement.

22

Accordingly, were we to amend our Amended and
Restated Articles to extend the date by which we are permitted to consummate our initial Business Combination, we would still need to
consummate our initial Business Combination on or prior to May 27, 2028 in order to avoid a suspension of our securities from trading
on and delisting from Nasdaq. If Nasdaq were to suspend our securities from trading and delist our securities, our securities could potentially
be quoted